Matronex Tablet
NDC Package 85622-200-30
Package Information
Matronex (ferrous fumarate, folic acid) tablets is matronex is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years.Matronex may be beneficial in improving the nutritional status of women prior to conception. This formulation utilizes a tablet delivery system. Marketed by Blue Heron Pharmaceuticals, Llc, this product is identified by NDC 85622-200.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 30 mg/1
- ASCORBIC ACID 120 mg/1
- CALCIUM CARBONATE 200 mg/1
- CHOLECALCIFEROL 20 ug/1
- CHOLINE BITARTRATE 55 mg/1
- CHROMIUM NICOTINATE 45 ug/1
- CYANOCOBALAMIN 10 ug/1
- FERROUS FUMARATE 27 mg/1
- FOLIC ACID 1000 ug/1
- MAGNESIUM OXIDE 20 mg/1
- MANGANESE SULFATE 2.6 mg/1
- MOLYBDENUM 50 ug/1
- NIACINAMIDE 20 mg/1
- POTASSIUM IODIDE 150 ug/1
- PYRIDOXINE HYDROCHLORIDE 50 mg/1
- RIBOFLAVIN 3.4 mg/1
- SELENIUM 70 ug/1
- THIAMINE MONONITRATE 3 mg/1
- VITAMIN A ACETATE 1500 ug/1
- ZINC OXIDE 25 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 85622 - Blue Heron Pharmaceuticals, Llc
- 85622-200 - Matronex
- 85622-200-30 - 30 TABLET in 1 BOTTLE
- 85622-200 - Matronex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85622-200-30 identifies a specific commercial package of 30 tablet in 1 bottle of Matronex, a human prescription drug labeled by Blue Heron Pharmaceuticals, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; calcium carbonate; cholecalciferol; choline bitartrate; chromium nicotinate; cyanocobalamin; ferrous fumarate; folic acid; magnesium oxide; manganese sulfate; molybdenum; niacinamide; potassium iodide; pyridoxine hydrochloride; riboflavin; selenium; thiamine mononitrate; vitamin a acetate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blue Heron Pharmaceuticals, Llc on September 11, 2025. The current certification is valid through December 31, 2026.
How is this Blue Heron Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85622020030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.